drugset / Trial / NCT00243022

Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme

NCT00243022

RandomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Giving the herb Boswellia serrata after surgery and radiation therapy may slow the growth of any remaining tumor cells. It is not yet known whether giving Boswellia serrata together with standard treatment is more effective than standard treatment alone in treating high-grade gliomas. PURPOSE: This randomized phase II trial is the study of a combination of complementary and alternative medicine (CAM) herbal supplement intervention as an adjuvant to standard treatment of patients with newly diagnosed and recurrent high-grade gliomas (HGG). The central hypothesis of this application is that a herbal preparation that inhibits 5-LO activity, will produce measurable biologically meaningful decrease in 5-LO eicosanoid production and brain edema that will be associated with improved survival and quality of life in patients with HGG.

Timeline

Start
2004-09
Primary completion
2010-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Boswellia Serrata Extract Unknown Oral
Background Vitamin B12 Other / unclassified Oral